210
Views
0
CrossRef citations to date
0
Altmetric
Review

Nano-Enabled Biomarker Discovery and Detection

&
Pages 387-396 | Published online: 09 Jun 2011

Bibliography

  • Atkinson AJ , ColburnWA, DeGruttolaVGet al. : Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.Clin. Pharmacol. Ther.69(3), 89–95 (2001).
  • Westermeier R , MarougaR: Protein detection methods in proteomics research.Biosci. Rep.25(1), 19–32 (2005).
  • Hamacher M , EisenacherM, StephanCet al. : Instruments and methods in proteomics. In: Data Mining in Proteomics. (Eds) . Humana Press, NJ, USA, 3–26 (2011).
  • Musselman I , SpeicherDW: Human serum and plasma proteomics.Curr. Protoc. Protein Sci.24, 24.1 (2005).
  • Posch A , MartosellaJ, ZolotarjovaN: Multi-component immunoaffinity subtraction and reversed-phase chromatography of human serum. In: 2D PAGE: Sample Preparation and Fractionation. Humana Press, NJ, USA, 27–39 (2008).
  • Nedelkov D , KiernanUA, NiederkoflerEE, TubbsKA, NelsonRW: Investigating diversity in human plasma proteins.Proc. Natl Acad. Sci. USA102(31), 10852–10857 (2005).
  • Olver CS , WebbTL, LongLJ, SchermanH, PrenniJE: Comparison of methods for depletion of albumin and IgG from equine serum.Vet. Clin. Pathol.39(3), 337–345 (2010).
  • Bellei E , BergaminiS, MonariEet al. : High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins.Amino Acids40(1), 145–156 (2010).
  • Fitzgerald A , WalshBJ: New method for prefractionation of plasma for proteomic analysis.Electrophoresis31(21), 3580–3585 (2010).
  • Albuquerque CP , SmolkaMB, PayneSH, BafnaV, EngJ, ZhouH: A multidimensional chromatography technology for in-depth phosphoproteome analysis.Mol. Cell Proteomics7(7), 1389–1396 (2008).
  • Chu C , LiuR: Application of click chemistry on preparation of separation materials for liquid chromatography.Chem. Soc. Rev.40(5), 2177–2188 (2011).
  • Bang H , EppsHL, ZhouXK, MazumdarM, WuZ, WuZ: Exploration, visualization, and preprocessing of high-dimensional data. In: Statistical Methods in Molecular Biology. Humana Press, NJ, USA, 267–284 (2010).
  • Wu CH , ChenC, BandeiraN: Protein identification by spectral networks analysis. In: Bioinformatics for Comparative Proteomics. Humana Press, NJ, USA, 151–168 (2011).
  • Domon B , AebersoldR: Options and considerations when selecting a quantitative proteomics strategy.Nat. Biotech.28(7), 710–721 (2010).
  • Becker CH , BernM: Recent developments in quantitative proteomics.Mutation Res. DOI: 10.1016/j.mrgentox.2010.06.016 (2010) (Epub ahead of print).
  • Askenazi M , MartoJA, LinialM: The complete peptide dictionary – a meta-proteomics resource.Proteomics10(23), 4306–4310 (2010).
  • Walls D , LoughranST, GeiserL, DayonL, VaezzadehAR, HochstrasserDF: Shotgun proteomics: a relative quantitative approach using off-gel electrophoresis and LC-MS/MS. In: Protein Chromatography. Humana Press, NJ, USA, 459–472 (2011).
  • Han X , AslanianA, YatesJR 3rd: Mass spectrometry for proteomics. Curr. Opin. Chem. Biol.12(5), 483–490 (2008).
  • Kim J , KimBC, Lopez-FerrerD, PetritisK, SmithRD: Nanobiocatalysis for protein digestion in proteomic analysis.Proteomics10(4), 687–699 (2010).
  • Wehr T : Top-down versus bottom-up approaches in proteomics.LCGC North Am.24(9), 1004–1010 (2006).
  • Macek B , WaandersLF, OlsenJV, MannM: Top-down protein sequencing and MS3 on a hybrid linear quadrupole ion trap-orbitrap mass spectrometer.Mol. Cell Proteomics5(5), 949–958 (2006).
  • McLafferty FW , BreukerK, JinMet al. : Top-down MS, a powerful complement to the high capabilities of proteolysis proteomics.FEBS J.274(24), 6256–6268 (2007).
  • Gautier JC , LéonardJF, CourcolM, GautierJC: Optimization of SELDI for biomarker detection in plasma. In: Drug Safety Evaluation. Humana Press, 351–368 (2011).
  • Liu H , HouD, WuD, YinH, WuX: Serum pattern profiling for analyzing different types of stress by protein chip technology: a preliminary study.Eur. J. Mass Spectrom.16(5), 619–623 (2010).
  • Cazares LH , DiazJI, DrakeRR, SemmesOJ: MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers.Methods Mol. Biol.428, 125–140 (2008).
  • Hall SE : Chemoproteomics-driven drug discovery: addressing high attrition rates.Drug Discov. Today11(11–12), 495–502 (2006).
  • Tate E : Recent advances in chemical proteomics: exploring the post-translational proteome.J. Chem. Biol.1(1), 17–26 (2008).
  • Oda Y , OwaT, SatoTet al. : Quantitative chemical proteomics for identifying candidate drug targets.Anal. Chem.75(9), 2159–2165 (2003).
  • Honda A , KomatsuH, KatoDet al. : Newly developed chemical probes and nano-devices for cellular analysis.Anal. Sci.24(1), 55–66 (2008).
  • Carlson EE : Natural products as chemical probes.ACS Chem. Biol.5(7), 639–653 (2010).
  • Cai D , RenL, ZhaoHet al. : A molecular-imprint nanosensor for ultrasensitive detection of proteins.Nat. Nanotechnol.5, 597–601 (2010).
  • Cui Y , WeiQ, ParkH, LieberCM: Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species.Science293(5533), 1289–1292 (2001).
  • Ndieyira JW , WatariM, BarreraADet al. : Nanomechanical detection of antibiotic-mucopeptide binding in a model for superbug drug resistance.Nat. Nanotechnol.3(11), 691–696 (2008).
  • Eustis S , El-SayedMA: Why gold nanoparticles are more precious than pretty gold: noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystals of different shapes.Chem. Soc. Rev.35, 209–217 (2006).
  • Baptista P , PereiraE, EatonPet al. : Gold nanoparticles for the development of clinical diagnosis methods.Anal. Bioanal. Chem.391(3), 943–950 (2008).
  • Yurkov G , FionovA, KoksharovY, KolesoV, GubinS: Electrical and magnetic properties of nanomaterials containing iron or cobalt nanoparticles.Inorg. Mater.43(8), 834–844 (2007).
  • Andrade ÂL, Souza DM, Pereira MC, Fabris JD, Domingues RZ: Magnetic properties of nanoparticles obtained by different chemical routes. J. Nanosci. Nanotechnol.9, 2081–2087 (2009).
  • Aubin-Tam M -E, Hamad-Schifferli K: Structure and function of nanoparticle–protein conjugates. Biomed. Mater.3(3), 034001 (2008).
  • Maus L , SpatzJP, FiammengoR: Quantification and reactivity of functional groups in the ligand shell of PEGylated gold nanoparticles via a fluorescence-based assay.Langmuir25(14), 7910–7917 (2009).
  • Porta F , SperanzaG, KrpeticZ, Dal Santo V, Francescato P, Scarì G: Gold nanoparticles capped by peptides. Mat. Sci. Eng. B140(3), 187–194 (2007).
  • Liu Y , ShiptonMK, RyanJ, KaufmanED, FranzenS, FeldheimDL: Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers.Anal. Chem.79(6), 2221–2229 (2007).
  • Geho DH , JonesCD, PetricoinEF, LiottaLA: Nanoparticles: potential biomarker harvesters.Curr. Opin. Chem. Biol.10(1), 56–61 (2006).
  • Cheng MM , CudaG, BunimovichYLet al. : Nanotechnologies for biomolecular detection and medical diagnostics.Curr. Opin. Chem. Biol.10(1), 11–19 (2006).
  • Shrivas K , WuHF: Modified silver nanoparticle as a hydrophobic affinity probe for analysis of peptides and proteins in biological samples by using liquid–liquid microextraction coupled to AP-MALDI-ion trap and MALDI-TOF mass spectrometry.Anal. Chem.80(7), 2583–2589 (2008).
  • Stumpo KA , RussellDH: Anion effects on ionization efficiency using gold nanoparticles as matrices for LDI-MS.J. Phys. Chem. C113(5), 1641–1647 (2009).
  • Sherrod SD , DiazAJ, RussellWK, CremerPS, RussellDH: Silver nanoparticles as selective ionization probes for analysis of olefins by mass spectrometry.Anal. Chem.80(17), 6796–6799 (2008).
  • Lin PC , TsengMC, SuAK, ChenYJ, LinCC: Functionalized magnetic nanoparticles for small-molecule isolation, identification, and quantification.Anal. Chem.79, 3401–3408 (2007).
  • Huang YF , ChangHT: Analysis of adenosine triphosphate and glutathione through gold nanoparticles assisted laser desorption/ionization mass spectrometry.Anal. Chem.79(13), 4852–4859 (2007).
  • Keighron JD , KeatingCD: Enzyme:nanoparticle bioconjugates with two sequential enzymes: stoichiometry and activity of malate dehydrogenase and citrate synthase on au nanoparticles.Langmuir26(24), 18992–19000 (2010).
  • Maus L , DickO, BadingH, SpatzJP, FiammengoR: Conjugation of peptides to the passivation shell of gold nanoparticles for targeting of cell-surface receptors.ACS Nano.4(11), 6617–6628 (2010).
  • Housni A , AhmedM, LiuS, NarainR: Monodisperse protein stabilized gold nanoparticles via a simple photochemical process.J. Phys. Chem. C112(32), 12282–12290 (2008).
  • Rosi NL , MirkinCA: Nanostructures in biodiagnostics.Chem. Rev.105, 1547–1562 (2005).
  • Luchini A , GehoDH, BishopBet al. : Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation.Nano. Letters8(1), 350–361 (2007).
  • Fredolini C , MeaniF, Alex ReederKet al.: Concentration and preservation of very low abundance biomarkers in urine, such as human growth hormone (hGH), by Cibacron Blue F3G-A loaded hydrogel particles.Nano. Research1(6), 502–518 (2008).
  • Longo C , PatanarutA, GeorgeTet al. : Core-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkers.PLoS One4(3), e4763 (2009).
  • Cerasoli E , RakowskaPD, HorganAet al. : MiS-MALDI: microgel-selected detection of protein biomarkers by MALDI-ToF mass spectrometry.Mol. Biosys.6(11), 2214–2217 (2010).
  • Miller G : Alzheimer‘s biomarker initiative hits its stride.Science326, 386–389 (2009).
  • Shankar GM , LiS, MehtaTHet al. : Amyloid-β protein dimers isolated directly from Alzheimer‘s brains impair synaptic plasticity and memory.Nat. Med.14(8), 837–842 (2008).
  • Krafft GA , KleinWL: ADDLs and the signaling web that leads to Alzheimer‘s disease.Neuropharmacology59(4–5), 230–242 (2010).
  • Grossman I , LutzM, CrenshawD, SaundersA, BurnsD, RosesA: Alzheimer‘s disease: diagnostics, prognostics and the road to prevention.EPMA J.1(2), 293–303 (2010).
  • Shaw LM , KoreckaM, ClarkCM, LeeVMY, TrojanowskiJQ: Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics.Nat. Rev. Drug Discov.6(4), 295–303 (2007).
  • Santos AN , TorklerS, NowakDet al. : Detection of amyloid-β; oligomers in human cerebrospinal fluid by flow cytometry and fluorescence resonance energy transfer.J. Alzheimers Dis.11(1), 117–125 (2007).
  • Nam JM , JangKJ, GrovesJT: Detection of proteins using a colorimetric bio-barcode assay.Nat. Protocols2(6), 1438–1444 (2007).
  • Willets KA , Van Duyne RP: Localized surface plasmon resonance spectroscopy and sensing. Ann. Rev. Phys. Chem.58(1), 267–297 (2007).
  • Georganopoulou DG , ChangL, NamJ-Met al.: Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer‘s disease.Proc. Natl Acad. Sci. USA102(7), 2273–2276 (2005).
  • Keating CD : Nanoscience enables ultrasensitive detection of Alzheimer‘s biomarker.Proc. Natl Acad. Sci. USA102(7), 2263–2264 (2005).
  • Solomon SB , SilvermanSG: Imaging in interventional oncology.Radiology257, 624–640 (2010).
  • Bathen TF , SitterB, Sj⊘bakkTE, TessemMB, GribbestadIS: Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation.Cancer Res.70, 6692–6696 (2010).
  • Turkbey B , PintoPA, ChoykePL: Imaging techniques for prostate cancer: implications for focal therapy.Nat. Rev. Urol.6(4), 191–203 (2009).
  • Kumar S , MohanA, GuleriaR: Biomarkers in cancer screening, research and detection: present and future: a review.Biomarkers11(5), 385–405 (2006).
  • Zhao J , PatwaTH, LubmanDM, SimeoneDM: Protein biomarkers in cancer: natural glycoprotein microarray approaches.Curr. Opin. Mol. Ther.10(6), 602–610 (2008).
  • Le Page CC , HuntsmanDG, ProvencherDM, Mes-MassonAM: Predictive and prognostic protein biomarkers in epithelial ovarian cancer: recommendation for future studies.Cancers2(2), 913–954 (2010).
  • Fleischhacker M , SchmidtB: Circulating nucleic acids (CNAs) and cancer – a survey.Biochim. Biophys. Acta1775(1), 181–232 (2007).
  • Huang ZH , LiLH, HuaD: Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients.Cancer Lett.243(1), 64–70 (2006).
  • Honeychurch J , GlennieMJ, IllidgeTM: Cyclophosphamide inhibition of anti-CD40 monoclonal antibody-based therapy of B cell lymphoma is dependent on CD11b+ cells.Cancer Res.65(16), 7493–7501 (2005).
  • Draghici S , ChatterjeeM, TainskyMA: Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens.Expert Rev. Mol. Diagn.5(5), 735–743 (2005).
  • Sreekumar A , PoissonLM, RajendiranTMet al. : Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.Nature457(7231), 910–914 (2009).
  • Couzin J : Metabolite in urine may point to high-risk prostate cancer.Science323(5916), 865 (2009).
  • Martinkova J , GadherSJ, HajduchM, KovarovaH: Challenges in cancer research and multifaceted approaches for cancer biomarker quest.FEBS Lett.583(11), 1772–1784 (2009).
  • Rowe MD , ThammDH, KraftSL, BoyesSG: Polymer-modified Gadolinium metal-organic framework nanoparticles used as multifunctional nanomedicines for the targeted imaging and treatment of cancer.Biomacromolecules10(4), 983–993 (2009).
  • Renu J , RobabehR, StevenGAet al. : In vivo magnetomotive optical molecular imaging using targeted magnetic nanoprobes.Proc. Natl Acad. Sci.USA107, 8085–8090 (2010).
  • Leber MF , EfferthT: Molecular principles of cancer invasion and metastasis.Int. J. Oncol.34, 881–895 (2009).
  • Ruoslahti E : Specialization of tumour vasculature.Nat. Rev. Cancer2, 83–90 (2002).
  • Bella A , LewisH, PhuJet al. : Conformationally constrained mimetics of laminin peptide YIGSR as precursors for antimetastatic disintegrins.J. Med. Chem.52(24), 7966–7969 (2009).
  • El-Sayed IH , HuangX, El-SayedMA: Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer.Nano Lett.5(5), 829–834 (2005).
  • El-Sayed IH , HuangX, El-SayedMA: Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles.Cancer Lett.239(1), 129–135 (2006).
  • Chanda N , KattumuriV, ShuklaRet al. : Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity.Proc. Natl Acad. Sci. USA107(19), 8760–8765 (2010).
  • Ananias HJK , van den Heuvel MC, Helfrich W, de Jong IJ: Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer. Prostate69(10), 1101–1108 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.